Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The aging/precancerous gastric mucosa: a pilot nutraceutical trial.

Marotta F, Barreto R, Tajiri H, Bertuccelli J, Safran P, Yoshida C, Fesce E.

Ann N Y Acad Sci. 2004 Jun;1019:195-9.

PMID:
15247013
2.

Effect of prolonged beta-carotene or DL-alpha-tocopheryl acetate supplementation on ornithine decarboxylase activity in human atrophic stomach mucosa.

Bukin YV, Draudin-Krylenko VA, Orlov EN, Kuvshinov YP, Poddubny BK, Vorobyeva OV, Shabanov MA.

Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):865-70.

3.

Oxidative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation.

Marotta F, Yoshida C, Barreto R, Naito Y, Packer L.

J Gastroenterol Hepatol. 2007 May;22(5):697-703.

PMID:
17444858
4.

Effects of antioxidant vitamin supplements on Helicobacter pylori-induced gastritis in Mongolian gerbils.

Sun YQ, Girgensone I, Leanderson P, Petersson F, Borch K.

Helicobacter. 2005 Feb;10(1):33-42.

PMID:
15691313
5.

[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].

Walecka-Kapica E, Knopik-Dabrowicz A, Klupińska G, Chojnacki J.

Pol Merkur Lekarski. 2008 Feb;24(140):95-100. Polish.

PMID:
18634262
6.

Decrease of ornithine decarboxylase activity in premalignant gastric mucosa and regression of small intestinal metaplasia in patients supplemented with high doses of vitamin E.

Bukin YV, Draudin-Krylenko VA, Kuvshinov YP, Poddubniy BK, Shabanov MA.

Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):543-6.

7.

Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.

Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, Carillo E, Cano E, Castro D, Andrade O, Sánchez V, Garcia R, Buiatti E, Aebischer C, Franceschi S, Oliver W, Muñoz N.

J Natl Cancer Inst. 2007 Jan 17;99(2):137-46.

PMID:
17227997
8.

[Expression of peroxisome proliferators-activated receptor-gamma and cyclooxygenase-2 in Helicobacter pylori infection-associated diseases and significance thereof].

Xie Y, Zhu J, Zhou XJ, Chen J, Lu NH, Wang CW.

Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2683-9. Chinese.

PMID:
17199977
9.

Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York.

Steenport M, Eom H, Uezu M, Schneller J, Gupta R, Mustafa Y, Villanueva R, Straus EW, Raffaniello RD.

Oncol Rep. 2007 Jul;18(1):235-40.

PMID:
17549373
10.

A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population.

Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agréus L.

Scand J Gastroenterol. 2005 Mar;40(3):302-11.

PMID:
15932171
11.

Chronic atrophic gastritis, gastric pH, nitrites and micronutrient levels in a population at risk for gastric carcinoma.

Jaskiewicz K, Van Helden PD, Wiid IJ, Steenkamp HJ, Van Wyk MJ.

Anticancer Res. 1990 May-Jun;10(3):833-6.

PMID:
2369096
12.

The gastric mucosa in gastric cancer patients in a low-incidence area.

Genta RM, Pusztaszeri M.

Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1085-93.

PMID:
16957515
13.

Multifocal atrophic gastritis: pathogenesis and therapeutic implications.

Rembiasz K, Budzynski A, Karcz D, Konturek PC, Konturek SJ, Stachura J.

Eur J Gastroenterol Hepatol. 2005 Aug;17(8):857-63.

PMID:
16003136
14.

Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.

de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ.

Gastroenterology. 2008 Apr;134(4):945-52. doi: 10.1053/j.gastro.2008.01.071. Epub 2008 Jan 30.

PMID:
18395075
15.

[Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].

Muller LB, Fagundes RB, Moraes CC, Rampazzo A.

Arq Gastroenterol. 2007 Apr-Jun;44(2):93-8. Portuguese.

16.

[Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].

Zhang XH, Huang B, Wang JL, Li YH, Mi JM, Shen HT, Zhang ZG, Yan X, Xing LX, Wang SJ.

Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):507-11. Chinese.

PMID:
17147114
17.

Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions.

Miao XP, Li JS, Li HY, Zeng SP, Zhao Y, Zeng JZ.

World J Gastroenterol. 2007 May 28;13(20):2867-71.

18.

Oxidative DNA damage and repair in chronic atrophic gastritis and gastric cancer.

Ni J, Mei M, Sun L.

Hepatogastroenterology. 2012 May;59(115):671-5. doi: 10.5754/hge12177.

PMID:
22469707
19.
20.

[The conditions of Helicobacter pylori colonization in different gastric diseases].

Liu YE, Yu XW, Dong NN, Gong YH, Sun LP, Yuan Y.

Zhonghua Yi Xue Za Zhi. 2008 Jan 22;88(4):230-2. Chinese.

PMID:
18361831

Supplemental Content

Support Center